Our results demonstrate that class IIa HDAC9 may have a specific role in breast carcinoma as it is overexpressed in the most aggressive breast tumor cell lines and tumors, stimulates cell proliferation and increases resistance to HDAC inhibitors. The gene discussed is HDAC9; the disease is breast neoplasm.